Mount Yale Investment Advisors, LLC Novo Nordisk A S Transaction History

Mount Yale Investment Advisors, LLC

$1.03 Billion
Q3 2024

A detailed history of Mount Yale Investment Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Mount Yale Investment Advisors, LLC holds 40,433 shares of NVO stock, worth $3.44 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares

40,433

Previous 42,573 5.03%

Holding current value

$3.44 Million

Previous $6.08 Million 20.77%

% of portfolio

0.47%

Previous 0.49%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	SELL	$119.07 - $145.42 $254,809 - $311,198	-2,140 Reduced 5.03%	40,433 $4.81 Million
Q2 2024 Aug 13, 2024	SELL	$122.71 - $146.91 $2.46 Million - $2.94 Million	-20,045 Reduced 32.01%	42,573 $6.08 Million
Q1 2024 May 15, 2024	BUY	$102.11 - $135.92 $86,895 - $115,667	851 Added 1.38%	62,618 $8.04 Million
Q4 2023 Feb 12, 2024	BUY	$87.78 - $105.45 $90,150 - $108,297	1,027 Added 1.69%	61,767 $6.39 Million
Q3 2023 Oct 11, 2023	BUY	$90.94 - $199.54 $2.45 Million - $5.38 Million	26,979 Added 79.91%	60,740 $5.52 Million
Q2 2023 Aug 14, 2023	BUY	$155.98 - $172.65 $929,484 - $1.03 Million	5,959 Added 21.43%	33,761 $5.46 Million
Q1 2023 May 11, 2023	SELL	$132.34 - $159.14 $119,238 - $143,385	-901 Reduced 3.14%	27,802 $4.42 Million
Q4 2022 Feb 13, 2023	BUY	$102.55 - $135.33 $24,612 - $32,479	240 Added 0.84%	28,703 $3.88 Million
Q3 2022 Nov 07, 2022	SELL	$95.28 - $116.93 $20,104 - $24,672	-211 Reduced 0.74%	28,463 $2.84 Million
Q2 2022 Aug 02, 2022	BUY	$103.24 - $121.81 $729,906 - $861,196	7,070 Added 32.73%	28,674 $3.2 Million
Q1 2022 May 03, 2022	BUY	$93.1 - $112.54 $2.01 Million - $2.43 Million	21,604 New	21,604 $2.4 Million
Q2 2019 Aug 13, 2019	SELL	$46.79 - $52.47 $469,303 - $526,274	-10,030 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$46.36 - $52.63 $1.43 Million - $1.62 Million	-30,802 Reduced 75.44%	10,030 $525,000
Q4 2018 Feb 14, 2019	BUY	$41.54 - $47.25 $381,295 - $433,707	9,179 Added 29.0%	40,832 $1.99 Million
Q3 2018 Nov 13, 2018	SELL	$46.76 - $51.24 $28,850 - $31,615	-617 Reduced 1.91%	31,653 $1.41 Million
Q2 2018 Aug 22, 2018	SELL	$44.29 - $50.42 $4,650 - $5,294	-105 Reduced 0.32%	32,270 $1.49 Million
Q1 2018 Jun 25, 2018	BUY	$48.49 - $58.14 $1.57 Million - $1.88 Million	32,375 New	32,375 $1.59 Million

Others Institutions Holding NVO

# of Institutions

1,957

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $192B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mount Yale Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mount Yale Investment Advisors, LLC with notifications on news.

Account

Mount Yale Investment Advisors, LLC Novo Nordisk A S Transaction History